The evaluation of antimicrobial resistance (AMR) governance across 193 countries is set to inform the upcoming 2026 Global Action Plan update. This comprehensive study, which spans from 2000 to 2021, highlights key governance indicators and their relationship to AMR-related outcomes. It aims to provide essential insights into national policies and practices, ultimately enhancing global efforts to combat AMR.
By constructing an indicator-based index, the study assesses governance across multiple domains, identifying temporal changes and associations with AMR outcomes. The data encompasses 190 United Nations Member States, alongside territories such as the Cook Islands, the State of Palestine, and Bermuda. This extensive dataset enables a nuanced understanding of the global AMR landscape, particularly within different regions defined by the World Health Organization (WHO).
Key Findings on AMR Governance
The study analyzed 832 national policy documents, retaining 269 for in-depth analysis. This included 200 National Action Plans (NAPs) and additional related policy documents. A collaborative effort involving four researchers ensured that governance indicators were rated based on established standards, with discrepancies resolved through discussions. The findings indicate significant variation in governance effectiveness across regions, particularly in areas such as human and animal antimicrobial employ (AMU), and AMR prevalence.
AMR prevalence was assessed using resistance rates from the WHO’s Bacterial Priority Pathogens List, providing a critical measure of the effectiveness of governance frameworks. The outcomes likewise included AMR-related mortality, which is categorized into deaths directly caused by AMR infections and those where AMR contributed to mortality but was not the direct cause. These metrics are crucial for evaluating the impact of national policies on public health.
Regional Insights and Data Handling
The study employed WHO’s regional classification system to capture differences in AMR governance trajectories. In Asia, for instance, the framework distinguishes between the Eastern Mediterranean, South-East Asia, and Western Pacific regions, reflecting the diverse challenges and successes faced by countries in these areas.
For countries with missing data, specific imputation strategies were used to maintain the integrity of comparisons. The data handling methods utilized advanced statistical approaches, including autoregressive integrated moving average (ARIMA) models, to project missing values while preserving temporal patterns. This thorough methodology underscores the study’s commitment to accuracy and reliability in its findings.
Expert Evaluation and Governance Framework
A structured governance evaluation framework was developed, drawing on insights from an international expert panel. This panel, consisting of 38 experts in fields such as clinical and veterinary medicine, refined the framework through discussions and surveys. Each indicator’s importance was scored using a five-point Likert scale, ensuring that only those deemed critical were included in the final framework.
The final governance index encompasses three primary domains: policy design, implementation, and monitoring. These are further divided into 14 subdomains and 46 indicators, providing a comprehensive picture of AMR governance. The study’s emphasis on expert judgment, combined with data-driven approaches, aims to create a robust framework that can effectively guide future policies.
Implications for Global Health Policy
The implications of this research extend beyond academic interest; they hold significant relevance for global health policy. As nations prepare for the 2026 Global Action Plan update, the findings will serve as a foundation for strengthening AMR governance worldwide. With AMR recognized as a critical threat to global health security, effective governance and robust policies are essential for mitigating its impact.
Key areas of focus moving forward include enhancing policy design and implementation, improving monitoring mechanisms, and fostering international collaboration. As countries adapt their strategies based on this comprehensive governance evaluation, the hope is to see improved outcomes in AMR prevalence and reduced mortality associated with resistant infections.
The study contributes to a growing body of evidence that underscores the importance of coordinated efforts in addressing AMR. Stakeholders are encouraged to review these findings and engage in discussions about enhancing governance frameworks in their respective regions.
As the global health community looks ahead, the emphasis will be on ensuring that the lessons learned from this evaluation lead to actionable strategies. The need for sustained commitment and innovative approaches to combat AMR remains critical.
For more detailed insights on AMR and its governance, interested readers are encouraged to explore resources from the World Health Organization and related public health entities.
As we move toward the 2026 update of the Global Action Plan, the insights gathered from this extensive evaluation will be pivotal in shaping effective responses to antimicrobial resistance. Your thoughts and feedback on this crucial topic are welcome.
